IBM Corporation (IBM)'s Watson Tries To Tackle Genetics Of Brain Cancer
3/20/2014 8:34:30 AM
This morning, IBM IBM +0.61% and the New York Genome Center announced a partnership to test whether Watson, the computer that won on Jeopardy, can sift through the genomes of cancer patients and help doctors pick drugs. This effort could hold the key to making DNA sequencing for cancer affordable, but there is a vast amount of work to do that will take years at a minimum.
Hey, check out all the research scientist jobs. Post your resume today!